Our plan is to stop cancer without stopping your life.
Remedy Plan is developing the first drugs that halt tumor growth and disrupt the cancer stem cells that cause metastasis.
Our approach aims to disrupt metastasis and tumor growth by inhibiting the properties of cancer stem cells that allow them to spread and resist chemotherapy.
Focusing on properties not found in healthy adult tissue ensures cancer stem cells are the only targets, making our approach both effective and non-toxic.
Our novel drug screening platform measures the most dangerous properties of cancer stem cells, allowing us to identify and develop drugs that disrupt proliferation and inhibit formation of new tumors.
- More on Our Science
The technology and research program at Remedy Plan are both exciting and novel. They have a great opportunity to develop drugs that effectively block cancer recurrence and metastasis.
Founder of Onyx Pharmaceuticals, professor at the UCSF Helen Diller Cancer Center, Fellow of Royal Society, and member of the National Academies of Science
- Lead Optimization
- Phase I
Through a proprietary drug screening platform, we are actively uncovering promising candidates that disrupt cancer stem cells and halt tumor growth.
This revolution in cancer treatment will be a game-changer for millions of people.
I'm very impressed by the creative and novel approach being used by Remedy Plan to identify new drugs that render cancer cells harmless.
Professor at UC Berkeley, member of the National Academies of Science, and an NIH Merit Award recipient